Savient Pharma (SVNT) Posts Q4 GAAP Loss of 1c; Launches KRYSTEXXA in U.S.
Tweet Send to a Friend
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) reported Q4 GAAP loss of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
